Ajjan, RA (2017) How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring? Diabetes Technology and Therapeutics, 19 (Suppl 2). S27-S36. ISSN 1520-9156
Abstract
Controlling glycemia in diabetes remains key to prevent complications in this condition. However, glucose levels can undergo large fluctuations secondary to daily activities, consequently creating management difficulties. The current review summarizes the basics of glucose management in diabetes by addressing the main glycemic parameters. The advantages and limitation of HbA1c, the gold standard measure of glucose control, are discussed together with the clinical importance of hypoglycemia and glycemic variability. The review subsequently moves focus to glucose monitoring techniques in diabetes, assessing advantages and limitations. Monitoring glucose levels is crucial for effective and safe adjustment of hypoglycemic therapy, particularly in insulin users. Self-monitoring of blood glucose (SMBG), based on capillary glucose testing, remains one of the most widely used methods to monitor glucose levels, given the relative accuracy, familiarity, and manageable costs. However, patient inconvenience and the sporadic nature of SMBG limit clinical effectiveness of this approach. In contrast, continuous glucose monitoring (CGM) provides a more comprehensive picture of glucose levels, but these systems are expensive and require constant calibration which, together with concerns over accuracy of earlier devices, restrict CGM use to special groups of patients. The newer flash continuous glucose monitoring (FCGM) system, which is more affordable than conventional CGM devices and does not require calibration, offers an alternative glucose monitoring strategy that comprehensively analyzes glucose profile while sparing patients the inconvenience of capillary glucose testing for therapy adjustment or CGM calibration. The fast development of new CGM devices will gradually displace SMBG as the main glucose testing method. Avoiding the inconvenience of SMBG and optimizing glycemia through alternative glucose testing strategies will help to reduce the risk of complications and improve quality of life in patients with diabetes.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © Ramzi A. Ajian, 2017; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
Keywords: | Self-monitoring of blood glucose (SMBG); Continuous glucose monitoring (CGM); Flash continuous glucose monitoring (FCGM); Type 1 diabetes (T1DM); Type 2 diabetes (T2DM); Hypoglycemia; Glycemic variability |
Dates: |
|
Institution: | The University of Leeds |
Depositing User: | Symplectic Publications |
Date Deposited: | 14 Jul 2017 15:24 |
Last Modified: | 14 Jul 2017 15:24 |
Status: | Published |
Publisher: | Mary Ann Liebert Inc. |
Identification Number: | 10.1089/dia.2017.0021 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:119068 |